Table 1

Clinical characteristics of MM patients

Patient no.Disease status at time of samplingGenderResponse to bortezomibBz (5 nM)Specific viability ex vivo (%) FK866 (3 nM)Combination (CI)
1DiagnosisMSensitive6672.441 (0.8)
2RelapseFSensitive54.468.835.6 (0.9)
3RelapseMResistant74.274.154.8 (0.8)
4RefractoryFResistant79.572.455.2 (0.7)
5RefractoryFResistant74.482.554.4 (0.5)
6RelapseFSensitive26400.5 (0.3)
7DiagnosisMSensitive63.984.546.48 (0.6)
8RelapseMResistant89.68873.4 (0.1)
9RelapseMSensitive5744.513 (0.7)
10RefractoryFResistant9389.163.4 (0.5)
11RefractoryFResistant92.492.469.2 (0.5)
  • Bz, bortezomib.